L. Benitez

发表

Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.

Patrick W. Burke, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia research.

Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents

P. Carver, L. Benitez, 2019, Drugs.

Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia

E. Hickey, L. Benitez, S. Sutphin, 2019, Leukemia & lymphoma.

Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

T. Phillips, Anthony J. Perissinotti, B. Marini, 2020, Clinical lymphoma, myeloma & leukemia.

Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy.

J. Griggs, D. Blayney, L. Petersen, 2017, Journal of oncology practice.

Oncology stewardship in acute myeloid leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2022, Annals of Hematology.

Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia

T. Kadia, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia & lymphoma.

Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.

D. Robinson, D. Bixby, Anthony J. Perissinotti, 2021, Cancer genetics.

Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation

B. Pulendran, Shuzhao Li, Paul Hakimpour, 2017, Science.

Oncology stewardship in acute myeloid leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2022, Annals of Hematology.

Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Leukemia & lymphoma.

Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice

K. Ravi, D. Bixby, Anthony J. Perissinotti, 2021, Leukemia & lymphoma.

Clofarabine Dosing in a Patient With Acute Myeloid Leukemia on Intermittent Hemodialysis: Case Report and Review of the Literature.

R. Mody, D. Frame, L. Benitez, 2017, Journal of pediatric hematology/oncology.

Risk factors for subtherapeutic levels of posaconazole tablet

C. Berglund, Anthony J. Perissinotti, J. Nagel, 2017, The Journal of antimicrobial chemotherapy.

PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia†

D. Bixby, Anthony J. Perissinotti, B. Marini, 2018, Leukemia & lymphoma.

Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Leukemia research.

Drugs That Act on the Immune System: Cytokines and Monoclonal Antibodies

F. M. Davis, L. Benitez, J. Cox, 2018 .

Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase

J. Auten, D. Bixby, Anthony J. Perissinotti, 2022, Leukemia & lymphoma.

Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.

A. Chinnaiyan, Xuhong Cao, K. Kasaian, 2017, Translational research : the journal of laboratory and clinical medicine.

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Annals of Hematology.

Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Infection Control & Hospital Epidemiology.

Efficacy of HMA +/- Venetoclax or Intensive Chemotherapy in Blast-Phase Myeloproliferative Neoplasms

M. Talpaz, D. Bixby, Anthony J. Perissinotti, 2021, Blood.

Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2021, Clinical lymphoma, myeloma & leukemia.

Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia

D. Bixby, Anthony J. Perissinotti, B. Marini, 2022, Leukemia & lymphoma.

Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management

Anna M. Brown, Victoria R. Nachar, D. Frame, 2021, Supportive Care in Cancer.

A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage

R. Hutchinson, D. Bixby, Anthony J. Perissinotti, 2019, Leukemia & lymphoma.

Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy

Anthony J. Perissinotti, B. Marini, Maressa Santarossa, 2015, Pediatric blood & cancer.

Mini‐HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Cancer.

Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring

D. Bixby, Anthony J. Perissinotti, B. Marini, 2023, Annals of Hematology.

Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia

Anthony J. Perissinotti, B. Marini, Taylor M Weis, 2023, International journal of hematology.

mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation

B. Pulendran, Shuzhao Li, Paul Hakimpour, 2017, Science.

Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia.

D. Bixby, Anthony J. Perissinotti, B. Marini, 2019, Blood advances.

Impact of Chemotherapy Educational Videos for Patients with Acute Myeloid Leukemia.

Anthony J. Perissinotti, B. Marini, L. Benitez, 2024, Journal of cancer education : the official journal of the American Association for Cancer Education.